申请人:Vertex Pharmaceuticals Incorporated
公开号:US20160340341A1
公开(公告)日:2016-11-24
The present invention relates to compounds useful as inhibitors of DNA-PK. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.